PC078

General

Cell Line

hPSCreg name PCIi030-A
Cite as:
PCIi030-A (RRID:CVCL_A8DG)
Alternative name(s)
PC078
Cell line type Human induced pluripotent stem cell (hiPSC)
Similar lines
PFIZi032-A
(B214c8)
Donor's gene variants:
TSC2
Donor diseases:
Tuberous Sclerosis
IMAGINi022-A
(IMAGINE022)
Donor diseases:
Waardenburg syndrome
PCIi026-A
(PC085)
Donor diseases:
Waardenburg syndrome
IMBAi017-A
(B002-ARID1B#8)
Donor diseases:
Coffin-Siris Syndrome
PCIi025-A
(PC084)
Donor diseases:
Waardenburg syndrome
PCIi032-A
(PC087)
Donor diseases:
Waardenburg Syndrome
SZGJMSi001-A
(ZLP-2)
Donor diseases:
Schizophrenia
SCVIi091-A
(SCVI2617)
Donor diseases:
transthyretin amyloidosis
INSRMi021-A
(PC177 3c14)
Donor diseases:
myofibrillar myopathy 1
KMUGMCi003-A
(KMUGMCi003ERCC2, KN610)
Donor diseases:
Trichothiodystrophy 1, Photosensitive
ZJSHi001-A
(ZJSHi-KCNB1)
Donor's gene variants:
KCNB1
Donor diseases:
developmental and epileptic encephalopathy, 26
WCHi006-A
Donor diseases:
Schizophrenia
CABi003-A
(DH05, AMDdh05-MiPS4F16)
Donor diseases:
Age-Related Macular Degeneration
USPi006-A
(DFNA58-ipsc-dup1-cl2)
Donor diseases:
autosomal dominant nonsyndromic deafness 58
USPi007-A
(DFNA58-ipsc-dup2-cl5)
Donor diseases:
autosomal dominant nonsyndromic deafness 58
SCTCi011-A
(IPS18-00072)
Donor diseases:
age-related macular degeneration
UKKi034-A
(NP0079-A, NP0079-7B)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
long QT syndrome 1
WCHi003-A
Donor diseases:
Schizophrenia
UKKi034-B
(NP0079-B, NP0079-15B)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
long QT syndrome 1
UKKi034-C
(NP0079-C, NP0079-16H)
Donor's gene variants:
KCNQ1, KCNQ1
Donor diseases:
long QT syndrome 1
ITXi013-A
(PT-R406W)
Donor's gene variants:
DES
Donor diseases:
Desminopathy
ITXi013-B
(IC-R406)
Donor's gene variants:
DES
Donor diseases:
Desminopathy
CMCi009-A
(CMC-BHD-001)
Donor's gene variants:
FLCN
Donor diseases:
Birt-Hogg-Dube Syndrome
SCTCi015-A
(IPS19-00051)
Donor diseases:
Age-Related Macular Degeneration
KMUGMCi001-A
(KMUGMCi001ACVRL1)
Donor diseases:
Telangiectasia, Hereditary Hemorrhagic
UOMi010-A
(ANCS-hiPSC-HPP5)
Donor diseases:
Hypophosphatasia
UOMi011-A
(ANCS-hiPSC-HPP6)
Donor diseases:
Hypophosphatasia
KSCBi010-A
(DKH005i-A, DKHi005-A)
Donor diseases:
Senior-Loken syndrome
HEBHMUi012-A
Donor diseases:
Hypertension
BBANTWi010-A
(iPSC_PBMC_LDS_TGFB3_KE2M_C9)
Donor diseases:
Loeys-Dietz syndrome 5
SHEHi002-A
(iPS36)
Donor's gene variants:
CACNA1C
Donor diseases:
Long QT Syndrome 8
KMUGMCi006-B
(TS271 #5 MT)
Donor diseases:
Tuberous Sclerosis
PCIi027-A
(PC086)
Donor diseases:
Waardenburg syndrome
KMUGMCi006-C
(TS271 #21 WT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-D
(TS271 #23 WT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-E
(TS271 #4 MT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-F
(TS271 #20 MT)
Donor diseases:
Tuberous Sclerosis
KMUGMCi006-A
(TS271 #12 WT)
Donor diseases:
Tuberous Sclerosis
Last update 8th December 2021
User feedback
No feedback available yet.

Login to share your feedback, experiences or results with the research community.

Provider

Generator PHENOCELL (PCI)
Owner Institut Curie
Derivation country France

External Databases

BioSamples SAMEA8944199
Cellosaurus CVCL_A8DG
Wikidata Q107116653

General Information

* Is the cell line readily obtainable for third parties?
No

Donor Information

General Donor Information

Sex female

Phenotype and Disease related information (Donor)

Diseases A disease was diagnosed.
The donor is a carrier of a disease-associated mutation and affected.
Synonyms
  • Waardenburg Syndrome Type I
  • Waardenburg Syndrome Type 1

Karyotyping (Donor)

Has the donor karyotype been analysed?
Unknown

Other Genotyping (Donor)

Is there genome-wide genotyping or functional data available?
No

External Databases (Donor)

BioSamples SAMEA8944200

Ethics

Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? Yes
Was the consent voluntarily given? Yes
Has the donor been informed that participation will not directly influence their personal treatment? Yes
Can you provide us with a copy of the Donor Information Sheet provided to the donor? Yes
Do you (Depositor/Provider) hold the original Donor Consent Form? Yes
Alternatives to consent are available? No
Is there other documentation provided to the donor for consenting purposes? No
Confirm that consent was obtained by a qualified professional Yes
Has the donor agreed to be re-contacted? Yes
Has the donor been informed about how her/his data will be protected? Yes
Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. pseudonymised
Does consent explicitly allow the derivation of pluripotent stem cells? Yes
Does consent expressly prevent the derivation of pluripotent stem cells? No
Does consent pertain to a specific research project? Yes
Details on restriction to research project Marie Skłodowska-Curie Innovative Training Network (ITN) NEUCrest project
Does consent permit unforeseen future research, without further consent? No
Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? No
Does consent expressly prevent development of commercial products? No
Does consent expressly prevent financial gain from any use of the donated embryo/tissue, including any product made from it? Yes
Does consent expressly permit storage of donated embryo/tissue for an unlimited time? No
Does consent expressly permit storage of cells derived from the donated embryo/tissue for an unlimited time? No
Does consent prevent the DONATED BIOSAMPLE from being made available to researchers anywhere in the world? Yes
Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? No

Does consent permit research by

an academic institution? Yes
a public organisation? Yes
a non-profit company? Yes
a for-profit corporation? Yes
Does consent expressly permit collection of genetic information? No
Does consent expressly permit storage of genetic information? No
Does consent prevent dissemination of genetic information? No
Has the donor been informed that their donated biosample or derived cells may be tested for the presence of microbiological agents / pathogens? Yes
Has the donor consented to receive information discovered during use of donated embryo/tissue that has significant health implications for the donor? Yes
How may genetic information associated with the cell line be accessed? Controlled Access
Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? No
Does the consent anticipate that the donor will be notified of results or outcomes of any research involving the donated samples or derived cells? Yes
Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? No
Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? No
Does consent permit access to medical records of the donor? No
Does consent permit access to any other source of information about the clinical treatment or health of the donor? No
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? Yes
Name of accrediting authority involved? Marie Skłodowska-Curie Innovative Training Network (ITN) NEUCrest
Approval number Grant Agreement 860635
Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the PROPOSED PROJECT, involving use of donated embryo/tissue or derived cells? Yes
Name of accrediting authority involved? Marie Skłodowska-Curie Innovative Training Network (ITN) NEUCrest
Approval number Grant Agreement 860635
Do you have obligations to third parties in regard to the use of the cell line? No
Are you aware of any further constraints on the use of the donated embryo/tissue or derived cells? No
Is there an MTA available for the cell line? No
For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used?
Are you aware of any constraints on the use or distribution of the cell line from the owner or any parties identified in the query above? No

hIPSC Derivation

General

Source cell type
A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes.
Synonyms
  • PERIPHERAL BLOOD MONONUCLEAR CELL
  • Peripheral Blood Mononuclear Cell
  • PBMC

Reprogramming method

Vector type Non-integrating
Vector Episomal
Is reprogramming vector detectable?
Unknown

Vector free reprogramming

Other

Selection criteria for clones Morphology
Derived under xeno-free conditions
Yes
Derived under GMP?
No
Available as clinical grade?
No

Culture Conditions

Surface coating Matrigel/Geltrex
Feeder cells
No
Passage method Enzymatically
Accutase
Medium mTeSR™ 1
Has Rock inhibitor (Y27632) been used at passage previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at cryo previously with this cell line?
No
Has Rock inhibitor (Y27632) been used at thaw previously with this cell line?
No

Characterisation

Analysis of Undifferentiated Cells
Marker Expressed Immunostaining RT-PCR Flow Cytometry Enzymatic Assay Expression Profiles
NANOG
Yes
POU5F1 (OCT-4)
Yes
SOX2
Yes
Differentiation Potency
Endoderm
Ont Id: UBERON_0000925
In vitro spontaneous differentiation
Marker Expressed
EOMES
Yes
GATA6
Unknown
Protocol or reference
Mesoderm
Ont Id: UBERON_0000926
In vitro spontaneous differentiation
Marker Expressed
HAND1
Yes
Protocol or reference
Ectoderm
Ont Id: UBERON_0000924
In vitro spontaneous differentiation
Marker Expressed
PAX6
Yes
Nestin
Yes
Protocol or reference

Microbiology / Virus Screening

HIV 1 Negative
Hepatitis B Negative
Hepatitis C Negative
Mycoplasma Negative

Genotyping

Karyotyping (Cell Line)

Has the cell line karyotype been analysed?
Yes
46,XX
Passage number: 10
Karyotyping method: G-Banding

Other Genotyping (Cell Line)